Literature DB >> 1101764

Mammalian somatic hybrids and human gene mapping.

R S Kucherlapati, F H Ruddle.   

Abstract

Somatic cell hybridization, as an aid in the study of human map, has made large strides during the past several years. Rodent-human hybrids are readily obtained, and selective systems are available to select hybrid cells to the exclusion of parenteral cells. Various species-specific genetic markers can be studied in the hybrids, and correlation of the expression of these markers with each other and with specific human chromosomes retained allows synteny analysis and chromosome assignment. Methods to determine the relative order of genes and their regional localization are also available. Using these methods, more than 60 human genes have been assigned to 22 human chromosomes.

Entities:  

Mesh:

Year:  1975        PMID: 1101764     DOI: 10.7326/0003-4819-83-4-553

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

1.  Cotransfer of circular and linear prokaryotic and eukaryotic DNA sequences into mouse cells.

Authors:  N Hsiung; H Warrick; J K deRiel; D Tuan; B G Forget; A Skoultchi; R Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

2.  Molecular organization of recombinant human-Arabidopsis chromosomes in hybrid cell lines.

Authors:  Yikun Liu; Yeng Mun Liaw; Chee How Teo; Petr Cápal; Naoki Wada; Kiichi Fukui; Jaroslav Doležel; Nobuko Ohmido
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

3.  DNA-mediated cotransfer of unlinked mammalian cell markers into mouse L cells.

Authors:  H Warrick; N Hsiung; T B Shows; R Kucherlapati
Journal:  J Cell Biol       Date:  1980-07       Impact factor: 10.539

4.  Pooled analysis of radiation hybrids identifies loci for growth and drug action in mammalian cells.

Authors:  Arshad H Khan; Andy Lin; Richard T Wang; Joshua S Bloom; Kenneth Lange; Desmond J Smith
Journal:  Genome Res       Date:  2020-09-02       Impact factor: 9.043

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.